Kura Oncology, Inc. (KURA)
10.65
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
10.72
+0.07
(+0.66%)
Pre-Market: 20:00
Kura Oncology Max Drawdown (5Y) : 86.69% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 86.69% |
| August 31, 2026 | 86.69% |
| July 31, 2026 | 86.69% |
| June 30, 2026 | 86.69% |
| May 31, 2026 | 86.69% |
| April 30, 2026 | 86.69% |
| March 31, 2026 | 86.69% |
| February 28, 2026 | 86.69% |
| January 31, 2026 | 86.69% |
| December 31, 2025 | 86.69% |
| November 30, 2025 | 86.69% |
| October 31, 2025 | 86.69% |
| September 30, 2025 | 86.69% |
| August 31, 2025 | 86.69% |
| July 31, 2025 | 86.67% |
| June 30, 2025 | 86.67% |
| May 31, 2025 | 86.67% |
| April 30, 2025 | 86.50% |
| March 31, 2025 | 84.14% |
| February 28, 2025 | 82.75% |
| January 31, 2025 | 82.75% |
| December 31, 2024 | 81.79% |
| November 30, 2024 | 81.79% |
| October 31, 2024 | 81.79% |
| September 30, 2024 | 81.79% |
| Date | Value |
|---|---|
| August 31, 2024 | 81.79% |
| July 31, 2024 | 81.79% |
| June 30, 2024 | 81.79% |
| May 31, 2024 | 81.79% |
| April 30, 2024 | 81.79% |
| March 31, 2024 | 81.79% |
| February 29, 2024 | 81.79% |
| January 31, 2024 | 81.79% |
| December 31, 2023 | 81.79% |
| November 30, 2023 | 81.79% |
| October 31, 2023 | 81.79% |
| September 30, 2023 | 79.72% |
| August 31, 2023 | 76.89% |
| July 31, 2023 | 76.89% |
| June 30, 2023 | 76.89% |
| May 31, 2023 | 76.89% |
| April 30, 2023 | 76.89% |
| March 31, 2023 | 74.27% |
| February 28, 2023 | 74.27% |
| January 31, 2023 | 74.27% |
| December 31, 2022 | 74.27% |
| November 30, 2022 | 74.27% |
| October 31, 2022 | 74.27% |
| September 30, 2022 | 74.27% |
| August 31, 2022 | 74.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Inovio Pharmaceuticals, Inc. | 99.62% |
| Fortress Biotech, Inc. | 98.41% |
| Spero Therapeutics, Inc. | 97.46% |
| Gossamer Bio, Inc. | 99.13% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -19.08 |
| Beta (5Y) | 0.4710 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 59.55% |
| Historical Sharpe Ratio (5Y) | -0.2412 |
| Historical Sortino (5Y) | -0.4679 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.92% |